Navigation Links
Martek Announces Addition to Its Board of Directors
Date:9/16/2009

COLUMBIA, Md., Sept. 16 /PRNewswire-FirstCall/ -- Martek Biosciences (Nasdaq: MATK) today announced the election of David M. Pernock to its Board of Directors.

Mr. Pernock brings to Martek's Board an extensive background in the commercialization of pharmaceutical products, having served from 1994 to 2009 in a variety of executive capacities for GlaxoSmithKline (GSK), one of the world's leading healthcare companies. In his most recent executive role, Mr. Pernock served as Senior Vice President in charge of GSK's pharmaceutical, vaccines, oncology, acute care and HIV divisions in the United States.

Mr. Pernock holds a Bachelor of Science degree in Business Administration from Arizona State University. He also currently serves on the Board of Directors of InstantDX, LLC, a privately-held provider of electronic prescribing services.

"We are pleased that David Pernock has accepted a position on Martek's Board," said Robert J. Flanagan, Martek's Chairman of the Board. "David's extensive experience in the healthcare industry provides Martek with a valuable resource."

Martek Biosciences Corporation is a leader in the innovation and development of omega-3 DHA products that promote health and wellness through every stage of life. The Company produces life'sDHA(TM), a vegetarian source of the omega-3 fatty acid DHA (docosahexaenoic acid), for use in foods, infant formula and supplements, and life'sARA(TM) (arachidonic acid), an omega-6 fatty acid, for use in infant formula. For more information on Martek Biosciences, visit http://www.martek.com.

    CONTACT
    Cassie France-Kelly
    Public Relations
    (443) 542-2116
    '/>"/>
SOURCE  Martek Biosciences Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 

Related biology technology :

1. Martek to Present at Two Upcoming Investor Conferences
2. Martek Announces Settlement of Patent Dispute with Capsugel France
3. Federal Circuit Rules in Marteks Favor in Appeal of Patent Infringement Case
4. Martek Signs Sole-Source Supply Agreement with Milk Powder Solutions
5. Martek to Announce Third Quarter 2009 Results
6. Martek Signs Sole-Source ARA Supply Agreement with Puleva Food S.L.
7. BP and Martek Biosciences Enter Joint Development Agreement to Deliver Advanced Biodiesels 
8. BP and Martek Biosciences Enter a Joint Development Agreement to Deliver Advanced Biodiesels
9. EU Committee Approves New Food Applications for Marteks lifesDHA(TM)
10. EU Committee Approves New Food Applications for Martek's life'sDHA™
11. Martek to Host Investor Conference Call to Discuss Research Presented at the International Conference on Alzheimers Disease in Vienna, Austria
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 23, 2013 VG Energy, an agricultural ... DAK Renewable Research to conduct field trials using ... Energy is a majority owned subsidiary of VG ... VG Energy,s exclusively licensed compound LipidMax selectively inhibits ... in plants, possessing a wide variety of applications ...
(Date:5/23/2013)... May 23, 2013 On April 19th ... to supermarkets to search for the growing antibiotic resistant ... Results from a year long study were released late ... foods, specifically meats, over previous years. For those suffering ... growth of antibiotic resistant bacteria in food, may eventually ...
(Date:5/23/2013)... Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and ... a teleconference to discuss its First Quarter 2013 financial ... information is provided below: Date: Thursday, May ... Dial-in: (800) 875-3456 (U.S.); (800) 648-0973 ( ... For those unable to participate in the ...
(Date:5/23/2013)... Tucson, Ariz. (PRWEB) May 23, 2013 ... world’s first and only FDA, Health Canada and CE ... Glasgow Science Centre in Scotland, which boasts more than ... Total Artificial Heart powered by the Freedom® portable ... one of the most advanced exhibitions of its kind. ...
Breaking Biology Technology:VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 2VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 3Acne Cream, Probiotic Action Shares News on How Some Food may Breed Acne Causing Bacteria 2Pressure BioSciences, Inc. to Discuss First Quarter 2013 Financial Results and Provide Business Update 2SynCardia Total Artificial Heart Featured in $3 Million Exhibition at Glasgow Science Centre 2SynCardia Total Artificial Heart Featured in $3 Million Exhibition at Glasgow Science Centre 3
... CITY, Mo., Aug. 28 Truman Medical Centers (TMC),became ... to install the,Siemens SOMATOM Definition AS 128 slice CT ... adaptive scanner, providing exceptional image,quality with minimal radiation exposure ... first medical facilities in the country to have this,truly, ...
... (NYSE: BRL ) today announced that its ... U.S. Food & Drug Administration,(FDA) to manufacture and ... (galantamine hydrobromide), 4 mg, 8 mg and 12 ... tablets product immediately., Barr filed an Abbreviated ...
... Brussels: THR), a biotechnology company focused on innovative,treatments ... today issuing a,business update and its financial results ... During the first half of 2008, ThromboGenics ... positioned the Company to successfully pursue the,next stage ...
Cached Biology Technology:Truman Medical Centers Becomes One of the First Hospitals in the U.S. To Install the World's First Adaptive 128-slice CT Scanner 2Barr Receives Approval for Generic Version of Razadyne(R) Tablets 2Barr Receives Approval for Generic Version of Razadyne(R) Tablets 3Barr Receives Approval for Generic Version of Razadyne(R) Tablets 4Barr Receives Approval for Generic Version of Razadyne(R) Tablets 5ThromboGenics Announces Half Year Results 2008 2ThromboGenics Announces Half Year Results 2008 3ThromboGenics Announces Half Year Results 2008 4ThromboGenics Announces Half Year Results 2008 5
(Date:5/23/2013)... be the world,s most popular fruit, can be made ... purple GM varieties. , "Working with GM tomatoes ... addition of a specific compound, allows us to pinpoint ... Cathie Martin from the John Innes Centre. , The ... flavour, health and shelf life characteristics because even higher ...
(Date:5/23/2013)... nucleosomes in the cell nucleus makes it unavailable ... in Munich now describes a mechanism that allows ... for transcription. , In higher organisms the genomic ... around disk-shaped particles called nucleosomes, each consisting of ... accommodating two loops of DNA. Packed in this ...
(Date:5/23/2013)... are billions of animal and plant specimens from birds, ... stacked, stored and preserved in jars and collection drawers. ... to understanding how the Earth,s biodiversity is changing in ... only the information were easily accessible. , A new ... a team from the University of Colorado Boulder, is ...
Breaking Biology News(10 mins):The world's favorite fruit only better-tasting and longer-lasting 2Biochemistry: Unspooling DNA from nucleosomal disks 2CU-Boulder helps tap crowds to digitize museum records of bugs and plants 2CU-Boulder helps tap crowds to digitize museum records of bugs and plants 3CU-Boulder helps tap crowds to digitize museum records of bugs and plants 4
... a spin-off of the Universitat Autònoma de Barcelona, in ... developed an artificial cellular model which faithfully reproduces the ... the carrying out of various lines of research related ... use live animals. , The basic structure of skin ...
... Pretreatment with double-dose anticlotting medication just before percutaneous coronary ... and cardiac death by half, according to a study ... Society for Cardiovascular Angiography and Interventions (SCAI), May 9?2, ... giving patients at least 600 mg of clopidogrel before ...
... Pigs carry hepatitis E virus (HEV), which they can pass ... Online Open Access journal BMC Veterinary Research says that pigs ... infection. The scenario humans need to worry about would occur ... rates, there is actually a higher chance pigs will pass ...
Cached Biology News:High-dose anticlotting drug cuts heart attack, death risk in half 2